Show simple item record

dc.contributor.editorSperti, Cosimo
dc.date.accessioned2022-05-06T11:33:41Z
dc.date.available2022-05-06T11:33:41Z
dc.date.issued2022
dc.identifierONIX_20220506_9783036534992_249
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/81183
dc.description.abstractPancreatic neoplasms include different pathological entities with variable biological behavior and different treatment modalities. Surgery and adjuvant therapy are the cornerstones of the therapeutic approach; however, even after radical resection, the majority of patients experience disease recurrence and the prognosis of pancreatic cancer remains dismal. A multimodal therapeutic approach, based on a combination of neoadjuvant therapy, chemotherapy, radiotherapy, immunotherapy and surgery, appears fundamental to improving the outcomes. This Special Issue of the Journal of Clinical Medicine, entitled “Recent Advances in Pancreatic Neoplasms”, focuses on possible new strategies to treat pancreatic neoplasms.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncologyen_US
dc.subject.otherPIWI proteins
dc.subject.otherPIWIL3
dc.subject.otherPIWIL4
dc.subject.otherpancreatic cancer
dc.subject.otherEMT
dc.subject.otherchemoresistance
dc.subject.othermotility
dc.subject.otherHNF4A
dc.subject.othersurvival
dc.subject.otherpancreatic neuroendocrine neoplasm
dc.subject.otherprimary pancreatic carcinoid
dc.subject.otherserotonin-secreting pancreatic tumour
dc.subject.otherserotonin-producing pancreatic tumour
dc.subject.otherneoadjuvant chemotherapy
dc.subject.otherresponse
dc.subject.othercarbohydrate antigen 19-9
dc.subject.otherfluorodeoxyglucose
dc.subject.otherpancreatectomy
dc.subject.otherpositron emission tomography
dc.subject.otherprognosis
dc.subject.otherstandardized uptake value
dc.subject.otherPancreatic ductal adenocarcinoma
dc.subject.othermicroRNAs
dc.subject.otherpancreatic fistula
dc.subject.otherpancreatic neoplasm
dc.subject.otherrenal cell carcinoma
dc.subject.otherpancreatic neoplasms
dc.subject.otherPET-CT scan
dc.subject.otherpancreatic ductal adenocarcinoma
dc.subject.otherpancreatic cancer prognosis
dc.subject.othercompletion total pancreatectomy
dc.subject.otherpooled analysis
dc.subject.otherrecurrent pancreatic cancer
dc.subject.otherrepeated pancreatectomy
dc.subject.otherpancreas
dc.subject.otherneuropathy
dc.subject.othertaxanes
dc.subject.otherbiomarker
dc.subject.otherC-reactive protein to albumin ratio
dc.subject.otherinflammation
dc.subject.otherintraductal papillary mucinous neoplasm
dc.subject.othermodified Glasgow prognostic score
dc.subject.otherneutrophyl lymphocite ratio
dc.subject.otherplatelet-to-lymphocyte ratio
dc.subject.otherrobotic pancreatic surgery
dc.subject.otherpancreato-gastrostomy
dc.subject.otherlow muscle mass
dc.subject.othersarcopenia
dc.subject.otherpancreatic adenocarcinoma
dc.subject.otherpancreatic surgery
dc.subject.otherbody composition
dc.subject.othern/a
dc.titleRecent Advances in Pancreatic Neoplasms
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-3500-5
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036534992
oapen.relation.isbn9783036535005
oapen.pages176
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/